SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: bd61b5b7f73f16c0
Drug Approval Canada Name: SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD
Product Name: SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD
Status: Marketed
Status Date: 2018-03-05
Original Market Date: 2018-03-05
Din: 02470411
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:32.04
Atc Original: C09BA04 PERINDOPRIL AND DIURETICS
Atc Name: c 09 ba 04
Aig Number: 0248401002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

INDAPAMIDE

0.625 MG

PERINDOPRIL ERBUMINE

2 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bd61b5b7f73f16c0

Type

Standard